Research shows new technique could cut time to detect polio in half
This is the first time that this type of scientific method has been used to detect polio
Read More
Tag: MHRA
Elfabrio receives vital MHRA authorisation
The therapy involves long-term enzyme replacement therapy for aduls with Fabry disease
Read More
Invizius gets MHRA Approval for H-Guard research
First-in-human study to be undertaken at the Manchester University Hospitals NHS Foundation Trust
Read More
GSK’s Arexvy authorised by MHRA
Therapy is the first respiratory syncytial virus vaccine specifically developed for older adults
Read More
Incyte’s Opzelura gets MHRA authorisation
Therapy involves the treatment of non-segmental vitiligo among adults and adolescents
Read More
CSL’s Hemgenix receives MHRA authorisation
Treatment is the only single infusion gene therapy for the treatment of severe haemophilia B
Read More
ABPI responds to rebooted MHRA clinical trials framework
Measures include a requirement to publicly register studies and share results among research participants
Read More
Celadon receives good manufacturing practice approval
MHRA approval relates to the company’s midlands-based drug development facilities
Read More
EQRx receives MHRA marketing approval for sugemalimab
Therapy treats patients with metastatic non-small cell lung cancer and has completed successful phase 3 trial
Read More
Otsuka receives vital Lupkynis MHRA authorisation
Therapy represents first oral calcineurin-inhibitor treatment for active lupus nephritis in adults
Read More
MHRA extends Cosentyx licence for paediatric arthritis
Data demonstrates that secukinumab shows a significantly longer time to flare versus placebo
Read More
Eli Lilly receives marketing authorisation for baricitinib
Treatment involves adult patients with severe alopecia areata
Read More
- UKHSA and ICL confirm variant which plays key role in global surge of Strep A infections
- Study reveals heart failure device could monitor patients and prevent hospitalisation
- MIT’s new MRI brain light-detecting technique could support brain cell studies
- PharmaTimes MSEA and NIEA awards are open for entry
- BBSRC invests £48m in Babraham Institute to advance lifelong health research
